Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
20-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
20-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
28 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aveo-oncology-an-lg-chem-company-announces-three-poster-presentations-at-asco-2025-annual-meeting-302438792.html
18 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aveo-oncology-an-lg-chem-company-presents-two-posters-for-tivozanib-at-the-2025-asco-gu-meeting-302377714.html
12 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aveo-oncology-an-lg-chem-company-announces-tivozanib-presentations-at-asco-gu-2025-302374155.html
16 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aveo-oncology-an-lg-chem-company-present-tinivo-2-results-and-tivo-3-exploratory-post-immunotherapy-survival-analysis-at-esmo-2024-302248624.html
03 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/aveo-oncology-an-lg-chem-company-announces-acceptance-of-late-breaking-oral-presentation-of-tinivo-2-results-at-esmo-2024-302235507.html
13 Jun 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/lg-chem-company-and-aveo-oncology-announce-lg-chems-first-proprietary-anti-cancer-compound-enters-phase-1-clinical-study-dosing-initiated-in-the-us-302171565.html
ABOUT THIS PAGE